Study Title and Description
Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene.
Key Questions Addressed
|3||Key Question 3. What are the harms of using medications to reduce risk for primary breast cancer? Key Question 3a. Do harms of risk-reducing medications vary by timing of initiation and/or duration of use? Key Question 3b. Do harms of risk-reducing medications persist beyond discontinuation of use?|
Primary Publication Information
|Title||Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene.|
|Author||McClung MR., Siris E., Cummings S., Bolognese M., Ettinger M., Moffett A., Emkey R., Day W., Somayaji V., Lee A.|
|Country||Oregon Osteoporosis Center, Portland, OR 97213, USA. email@example.com|
|Year||-- Not Found --|
Pubmed ID: 16735934
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Key Questions 1-4
Results & Comparisons
No Results found.